<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2021.8098</article-id>
<article-id pub-id-type="publisher-id">OR-0-0-8098</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Shi</surname><given-names>Ying</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Huang</surname><given-names>Jianjun</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Jun</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Ying</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Fu</surname><given-names>Xiaodan</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Yimin</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Yin</surname><given-names>Gang</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Wen</surname><given-names>Jifang</given-names></name></contrib>
</contrib-group>
<pub-date pub-type="ppub">
<month>07</month>
<year>2021</year></pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>05</month>
<year>2021</year></pub-date>
<volume>46</volume>
<issue>1</issue>
<elocation-id>147</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Shi et al.</copyright-statement>
<copyright-year>2021</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 34: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="34" page="399" id="RA1" xlink:href="10.3892/or.2015.3986" ext-link-type="doi">399-406</related-article>, 2015; DOI: 10.3892/or.2015.3986</p>
<p>Following the publication of this paper, it was drawn to the Editors attention by a concerned reader that certain of the cell Transwell assay data in the article (featured in Figs. 3B and 6B) were strikingly similar to data that appearing in different form in another article by different authors at different research institutions, which had already been published elsewhere at the time of the present articles submission.</p>
<p>Owing to the fact that the contentious data in the above article had already appeared in different form in another article prior to its submission to <italic>Oncology Reports</italic>, the Editor has decided that this paper should be retracted from the Journal. The authors did not reply to indicate whether or not they agreed with the retraction of the paper. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
